Abstract:
The Chicago Illinois Technology Enterprise Center (Chicago-ITEC) today announced four new additions to their portfolio of life sciences and technology companies. Investments were made in Genomics USA, Inc.; Immune Cell Therapy, Inc.; Lambda Vision, Inc; and DermaAegis, Inc. These new investments bring the total number of companies in which Chicago-ITEC has invested to ten.